Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics United States | 272 | 278 |
|
PreventionGenetics United States | 157 | 171 |
|
Genetic Services Laboratory University of Chicago United States | 289 | 481 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics United States | 106 | 83 |
|
Charcot-Marie-Tooth - Comprehensive Panel PreventionGenetics United States | 53 | 44 |
|
Charcot-Marie-Tooth - Demyelinating Neuropathy Panel PreventionGenetics United States | 34 | 24 |
|
PreventionGenetics United States | 44 | 41 |
|
Congenital Cataracts Facial Dysmorphism Neuropathy (CCFDN) Syndrome via the CTDP1 Gene PreventionGenetics United States | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Cataract panel. NGS panel of 69 genes. Genologica Medica Spain | 146 | 69 |
|
Congenital cataracts, facial dysmorphism, and neuropathy: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
CTDP1 - (c.863+389C>T) mutation detection Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC Netherlands | 1 | 1 |
|
Congenital Cataracts NGS Panel Fulgent Genetics United States | 106 | 56 |
|
Congenital Cataracts, Facial Dysmorphism, And Neuropathy (CTDP1 Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.